From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Mon, 11 Aug 2008 14:28:51 -0500 (CDT)
Subject: CDER New 8/11/2008
| ||||||||||||
August 11, 2008
- New and Generic Drug Approvals
- Azor (amlodipine besylate and olmesartan medoxomil) Tablets, Daiichi Sankyo, Inc., Labeling Revision
- Cefepime Injection, Baxter Healthcare Corp., Approval
- Cialis (tadalafil) Tablets, Eli Lilly and Co., Labeling Revision
- Corzide (bendroflumethiazide and nadolol) Tablets, King Pharmaceuticals, Labeling Revision
- Femara (letrozole) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision
- Kerlone (betaxolol hydrochloride) Tablets, Sanofi-Aventis US, LLC, Labeling Revision
- Ramipril Capsules, Cipla Ltd, Approval
- Talacen (acetaminophen and pentazocine hydrochloride) Tablets, Sanofi-Aventis US, LLC, Labeling Revision
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
